| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.558002 |
| 003 | CaOODSP |
| 005 | 20210624172153 |
| 007 | cr ||||||||||| |
| 008 | 150406s2001||||xxc|||||o f|0| 0 eng d |
| 020 | |a0-662-31340-2 |
| 022 | |a1499-3503 |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aH13-5/01-1E-PDF|zH13-5/01-1E-IN |
| 100 | 1 |aBlomqvist, Ake G.,|d1941- |eauthor. |
| 245 | 10|aPharmacare in Canada : |bissues and options / |cAke Blomqvist, Jing Xu. |
| 260 | |bHealth Canada, |c2001. |
| 300 | |a1 online resource (vi, 27 pages). |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 490 | 1 |aHealth policy working paper series ; |x1499-3503|v01-01 |
| 500 | |aCat. No (H13-5/01-1E) and ISBN (0-662-31030-6) for the paper version have been printed on the PDF version. |
| 504 | |aIncludes bibliographical references. |
| 520 | 3 |a"This paper, commissioned by Health Canada in December 2000, covers various options for a possible federal initiative in the pharmacare area. The objective at this stage is not to recommend any particular new policy or plan, but rather to outline a variety of options and to identify areas where additional research would be useful as a basis for future policy development"--Introduction. |
| 590 | |a04-44|b2004-10-29 |
| 710 | 1 |aCanada.|bHealth Canada. |bInformation, Analysis and Connectivity Branch, |eissuing body. |
| 775 | 08|tL'Assurance-médicaments au Canada : |w(CaOODSP)9.590997 |
| 776 | 0#|tPharmacare in Canada: issues and options / |w(CaOODSP)9.615750 |
| 830 | #0|aHealth policy working paper series,|x1499-3503|v01-01|w(CaOODSP)9.504465 |
| 856 | 40|ahttp://publications.gc.ca|qPDF|s147 KB|uhttps://publications.gc.ca/collections/Collection/H13-5-01-1E.pdf|y01-01 |